NEDD4 Depletion Inhibits Hepatocellular Carcinoma Growth via Targeting PTEN
Author(s) -
Xiaofeng Hang,
Shanbang Zhu,
DI Hong-wei,
Zhiqin Wu,
Kaijian Chu,
Junxue Wang,
Haiguang Xin,
Guanzhen Yu,
Haoran Peng,
Xiaohui Miao,
Wensheng Xu
Publication year - 2016
Publication title -
cellular physiology and biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.486
H-Index - 87
eISSN - 1421-9778
pISSN - 1015-8987
DOI - 10.1159/000445667
Subject(s) - pten , cancer research , nedd4 , hepatocellular carcinoma , tensin , cell growth , gene silencing , cell , biology , carcinogenesis , cancer , medicine , pi3k/akt/mtor pathway , signal transduction , ubiquitin , microbiology and biotechnology , ubiquitin ligase , gene , biochemistry , genetics
Neural precursor cell-expressed developmentally down-regulated gene 4 (NEDD4) plays an important role in tumor cell growth, yet its role in hepatocellular carcinoma (HCC) remains unclear. This study is to establish NEDD4 as a prognostic biomarker by which the survival of HCC patients can be predicted and to reveal the role of NEDD4 in hepatocellular carcinoma cell growth.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom